Skip to content

EV / sales at other companies

Abbott logo
AbbottABT
4.6×-1.0×
Johnson & Johnson logo
Johnson & JohnsonJNJ
6.5×+1.8×
Stryker logo
StrykerSYK
5.4×-1.3×
Edwards Lifesciences logo
Edwards LifesciencesEW
-0.2×
Medtronic logo
MedtronicMDT
3.6×-0.4×
STERIS logo
STERISSTE
3.9×-0.5×

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$66.81B-37.5%
P/E18.8×-34.0×
P/S3.2×-2.8×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Calculated from Boston Scientific’s reported figures.

Based on the most recent quarter.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's EV / sales?
Boston Scientific (BSX) reported EV / sales of 7× in Q4 2025.
How has Boston Scientific's EV / sales changed year-over-year?
Boston Scientific's EV / sales decreased by 17.4% year-over-year, from 8.5× to 7×.
What is the long-term trend for Boston Scientific's EV / sales?
Over 4 years (2021 to 2025), Boston Scientific's EV / sales has grown at a 7.7% compound annual growth rate (CAGR), from 24.7× to 33.2×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.